Search research articles
Contact Us
Filters
Showing results (111-120 of 123) with videos related to
Page
of 13
Sort By:
Plos One
|
October 4, 2014
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial
Ashish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism
K Biggadike, R M Angell, C M Burgess, et al.
Journal of Medicinal Chemistry
|
September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin Inhibitors
Panayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
British Journal of Haematology
|
August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia
C J Knechtli, N J Goulden, J P Hancock, et al.
Blood
|
December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
C J Knechtli, N J Goulden, J P Hancock, et al.
Journal of Medicinal Chemistry
|
March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis
Panayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Journal of Medicinal Chemistry
|
September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
Panayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Medicinal Chemistry
|
February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists
Panayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Journal of Medicinal Chemistry
|
June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>
Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 123) with videos related to
Sort By:
Page
of 13
Plos One
|
October 4, 2014
Outcome of central nervous system relapses in childhood acute lymphoblastic leukaemia--prospective open cohort analyses of the ALLR3 trial
Ashish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, et al.
Journal of Medicinal Chemistry
|
January 14, 2000
Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism
K Biggadike, R M Angell, C M Burgess, et al.
Journal of Medicinal Chemistry
|
September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic α<sub>v</sub>β<sub>6</sub> Integrin Inhibitors
Panayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
British Journal of Haematology
|
August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia
C J Knechtli, N J Goulden, J P Hancock, et al.
Blood
|
December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia
C J Knechtli, N J Goulden, J P Hancock, et al.
Journal of Medicinal Chemistry
|
March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis
Panayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Journal of Medicinal Chemistry
|
September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
Panayiotis A Procopiou, Niall A Anderson, John Barrett, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Journal of Medicinal Chemistry
|
February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists
Panayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Journal of Medicinal Chemistry
|
June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>
Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Page
of 13